I listened to Yahoo Finance this morning, where Interactive Brokers' chief strategist mentioned that investors typically sell losers and hold on to winners at the end of the year. This makes sense, considering tax planning.
Based on this, I expected the losers to perform worse toward the end of the year. However, I did a quick backtest to analyze which stocks perform best and worst during this period. To my surprise, it’s the stocks that have lost the most that perform best in the last few days of the year, while the stocks with the best performance tend to do the worst during this time.
If you buy the 10 worst performers on the first trading day after December 25th and hold them until the first trading day of the new year, the results are as follows:
- S&P 500 stocks: 2.06% return
- Russell 2000 stocks: 6.54% return
- Dow Jones stocks: 0.76% return
If you buy the 10 best performers during the same period, the results are:
- S&P 500 stocks: -0.28% return
- Russell 2000 stocks: -1.31% return
- Dow Jones stocks: 0.02% return
The results appear consistent across different universes—buying the losers at the end of the year seems to be a better strategy.
This backtest was conducted using data since 2003 with a 245-day Rate of Change (ROC).
What is less surpricing is that most of the return comes over New Years day. This is the result of you buy the worst 20 stocks of the year in R3000 and hold them over New Years.
These are the candidates for this new years.
Ticker | Name |
---|---|
GOEV | Canoo, Inc. |
CDT | Conduit Pharmaceuticals, Inc. |
MOND | Mondee Holdings, Inc. |
SAVEQ | Spirit Airlines, Inc. |
BNAI | Brand Engagement Network, Inc. |
CABA | Cabaletta Bio, Inc. |
SAVA | Cassava Sciences, Inc. |
IVVD | Invivyd, Inc. |
VRCA | Verrica Pharmaceuticals, Inc. |
LAZR | Luminar Technologies, Inc. |
ALXO | ALX Oncology Holdings, Inc. |
STTK | Shattuck Labs, Inc. |
EDIT | Editas Medicine, Inc. |
CBUS | Cibus, Inc. |
AVTE | Aerovate Therapeutics, Inc. |
HLVX | HilleVax, Inc. |
CHGG | Chegg, Inc. |
WOLF | Wolfspeed, Inc. |
INO | Inovio Pharmaceuticals, Inc. |
AGEN | Agenus, Inc. |